Loading insider details...
Beta
Latest Form 4 (Sep 1, 2026): Disposition to Issuer of 6,400 CRNX shares, $544.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 1, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to Issuer | 6,400 | $544.0K |
| Jun 22, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 5,925 | n/a |
| Jun 18, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 6,292 | $224.1K |
| Mar 12, 2026 | PTC THERAPEUTICS, INC. (PTCT) | Exercise/Conversion | 1,167 | $39.2K |
| Mar 9, 2026 | PTC THERAPEUTICS, INC. (PTCT) | Sale | 6,333 | $401.4K |
| Mar 4, 2026 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale | 3,000 | $119.0K |
| Jan 6, 2026 | PTC THERAPEUTICS, INC. (PTCT) | Grant/Award | 4,000 | n/a |
| Nov 21, 2025 | PTC THERAPEUTICS, INC. (PTCT) | Gift | 867 | n/a |
| Jun 13, 2025 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/Award | 6,900 | n/a |
| Mar 17, 2025 | PTC THERAPEUTICS, INC. (PTCT) | Sale | 5,000 | $270.0K |